Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-05-02
2006-05-02
Spector, Lorraine (Department: 1646)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S252300, C435S325000, C435S006120, C536S023500, C530S351000
Reexamination Certificate
active
07037685
ABSTRACT:
Disclosed are created stable polypeptides which are capable of inducing the production of interferon-gamma by immunocompetent cells. The present polypeptides contain specific amino acid sequences usually derived from the wild-type polypeptides, being capable of the production of interferon-gamma, by replacing the cysteine(s) with different amino acid(s). The present polypeptides possess a stability and an activity of inducing the production of IFN-γ by immunocompetent cells, both of which are significantly higher than those of the wild-type polypeptides. In addition to the activity, the present polypeptides can exhibit remarkable activities of inducing the formation of killer cells and enhancing thier cytotoxicities. The present polypeptides are easily obtainable by the process according to the present invention using recombinant DNA techniques. Thus the present polypeptides are useful for agents to treat and/or prevent susceptive diseases such as viral diseases, infections, malignant tumors, and immunopathies.
REFERENCES:
patent: 4518584 (1985-05-01), Mark et al.
patent: 5776731 (1998-07-01), Parnet et al.
patent: 5912324 (1999-06-01), Okamura et al.
patent: 6214584 (2001-04-01), Ushio et al.
patent: 0712931 (1996-05-01), None
patent: 0692536 (1996-01-01), None
patent: 827189 (1996-01-01), None
patent: 0712931 (1996-05-01), None
patent: 8193098 (1996-07-01), None
patent: 8217798 (1996-08-01), None
patent: 8231598 (1996-09-01), None
patent: 0767178 (1997-04-01), None
patent: WO 9744468 (1997-11-01), None
patent: 0819757 (1998-01-01), None
patent: 0821005 (1998-01-01), None
Balwill, “Cytokines in cancer therapy”,Oxford Medical Publications(1989).
Laemili, Cleavage of structural proteins during the assembly of the head of bacteriophage T4,Nature, 227:680-685 (1970).
Horton et al., “G4ene splicing by overlap extension”,Methods in Enzymology, 217:270-279 (1993).
Henco et al., “Structural relationship of human interferon alpha genes and pseudogenes”,J. Mol. Biol., 185:227-260 (1985).
Fujioka et al., “Combination of lymphokine-activated killer cells and interleukin-2 in treating metastatic renal cell carcinoma”,British Journal of Urology, 73:23-31 (1994).
Hay et al., “ATCC cell lines and hybridomas”,American Type Culture Collection, 8thedition (1994).
Shimada et al., “Basic techniques for the gene therapy”,Biomanual Up Series(1996).
Yokota et al., “The experimental methods for the gene cloning”,Biomanual Series 3(1993).
Kuroki et al., “The handbook for the cell engineering”,Saibo-Kogaku Handbook, (1992).
“Riken Cell Bank”,Cell Line Catalog, 9:77 and 234 (1996).
Okamura et al.,Nature, 378:88-91 (1995).
Ushio et al.,J. Immunol., 156:4274-4279 (1995).
Kurimoto Masashi
Okamoto Iwao
Yamamoto Kozo
Browdy and Neimark PLLC
Jiang Dong
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
Spector Lorraine
LandOfFree
DNA encoding loypeptides having interferon-γ inducing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA encoding loypeptides having interferon-γ inducing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA encoding loypeptides having interferon-γ inducing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3631445